UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
UCB Disclosure Form for Purchase of Celltech Shares LONDON, June 9 /PRNewswire-FirstCall/ -- UCB S.A. made the following disclosure today: This announcement was publicly made in the United...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.825 | -1.95327460743 | 195.825 | 195.825 | 192 | 251 | 192 | CS |
4 | -6.275 | -3.16479636868 | 198.275 | 200 | 192 | 95 | 194.90031386 | CS |
12 | -2.76 | -1.41712877388 | 194.76 | 200 | 174 | 207 | 189.3116318 | CS |
26 | 42.12 | 28.1024819856 | 149.88 | 200 | 149.85 | 199 | 180.54737207 | CS |
52 | 92 | 92 | 100 | 200 | 100 | 262 | 146.98920405 | CS |
156 | 93.85 | 95.6189505858 | 98.15 | 200 | 68.301062 | 652 | 94.24394919 | CS |
260 | 96.15 | 100.312989045 | 95.85 | 200 | 67.39 | 853 | 94.62787041 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관